NasdaqGM:LGNDPharmaceuticals
A Look At Ligand Pharmaceuticals (LGND) Valuation After Strong Multi Year Shareholder Returns
Ligand Pharmaceuticals (LGND) has been drawing attention after recent share performance data highlighted mixed short term returns alongside stronger longer term outcomes, prompting investors to reassess how its current pricing lines up with fundamentals.
See our latest analysis for Ligand Pharmaceuticals.
At a share price of $199.62, Ligand Pharmaceuticals has seen short term share price pressure, with a 7 day return of 2.41% and a 30 day return of 1.45%. Longer horizons show stronger...